Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Chinese Patent Office
Chubb
Teva
Cipla
Queensland Health
Baxter
Johnson and Johnson

Generated: May 25, 2018

DrugPatentWatch Database Preview

ATOMOXETINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Atomoxetine Hydrochloride, and when can generic versions of Atomoxetine Hydrochloride launch?

Atomoxetine Hydrochloride is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Glenmark Pharms Ltd, Teva Pharms Usa, and Zydus Pharms Usa Inc. and is included in six NDAs.

The generic ingredient in ATOMOXETINE HYDROCHLORIDE is atomoxetine hydrochloride. There are fourteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. There are seven tentative approvals for this compound. Additional details are available on the atomoxetine hydrochloride profile page.
Drug patent expirations by year for ATOMOXETINE HYDROCHLORIDE
Pharmacology for ATOMOXETINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for ATOMOXETINE HYDROCHLORIDE
Synonyms for ATOMOXETINE HYDROCHLORIDE
(-)-N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride
(-)-N-Methyl-3-phenyl-3-(o-tolyloxy)propylamine hydrochloride
(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine hydrochloride
(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine hydrochloride
(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride
(R)-(-)-N-methyl-3-(2-methylphenoxy)-3-phenylpropylamine hydrochloride
(R)-(-)-Tomoxetine hydrochloride
(R)-ATOMOXETINE HYDROCHLORIDE
(R)-N-Methyl-?-(2-methylphenoxy)-benzenepropanamine hydrochloride
(R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine Hydrochloride
(R)-N-METHYL-3-PHENYL-3-(O-TOLYLOXY)PROPAN-1-AMINE HCL
(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride
(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-aminehydrochloride
(R)-N-Methyl-gamma-(2-methyl-phenoxy)benzenepropanamine hydrochloride
(r)-n-methyl-gamma-(2-methylphenoxy)-benzenepropanamine hydrochloride
(R)-N-METHYL-GAMMA-(2-METHYLPHENOXY)BENZENEPROPANAMINE HYDROCHLORIDE
(R)-Tomoxetine hydrochloride
(R)-Tomoxetine hydrochloride, solid
248T597
57WVB6I2W0
82248-59-7
83015-26-3 (Parent)
AB0014234
AB25136
AC1L1HTF
AK-72912
AKOS015920150
AM20060733
Ambap82248-59-7
AN-11139
API0001557
AT-20429
Atomexine Hydrochloride, pharmaceutical secondary standard
ATOMOXETIN HCL
Atomoxetine (hydrochloride)
Atomoxetine for impurity A identification, European Pharmacopoeia (EP) Reference Standard
Atomoxetine HCL
Atomoxetine hydrochloride (JAN/USP)
Atomoxetine hydrochloride [USAN]
Atomoxetine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Atomoxetine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Atomoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Atomoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard
BENZENEPROPANAMINE, N-METHYL-G-(2-METHYLPHENOXY)-, HYDROCHLORIDE (1:1), (GR)-
Benzenepropanamine, N-methyl-gamma-(2-methylphenoxy)-, hydrochloride, (-)-
BR-72912
C17H21NO.HCl
CAS-82248-59-7
CCG-100874
CHEBI:331697
CHEMBL1702
CPD000469177
CS-1085
D02574
DSSTox_CID_24266
DSSTox_GSID_44266
DSSTox_RID_80136
DTXSID2044266
F0001-2408
FT-0655350
HY-17385
K464
KS-1223
LS-177676
LUCXVPAZUDVVBT-UNTBIKODSA-N
LY 139603
LY 139603 HYDROCHLORIDE
LY-135252
LY-139602 [(+)-isomer]
LY-139603
LY139603
M-1314
METHYL-((R)-3-PHENYL-3-O-TOLYLOXY-PROPYL)-AMINE HYDROCHLORIDE
MFCD06410992
MLS001401377
MLS002153176
MolPort-003-983-468
NC00124
NCGC00016056-02
NCGC00025345-02
OR348051
s3175
SAM001246626
SC-17967
SCHEMBL122111
SMR000469177
ST24020766
Strattera
Strattera (TN)
Tomoxetine
Tomoxetine HCl
TOMOXETINE HYDROCHLORIDE
tomoxetine hydrochloride, (-)-isomer
Tox21_110292
Tox21_110292_1
UNII-57WVB6I2W0

US Patents and Regulatory Information for ATOMOXETINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 079017-006 Sep 17, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 079022-004 May 30, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Pharms Ltd ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 079019-007 May 30, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 079022-005 May 30, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Colorcon
Harvard Business School
Moodys
Federal Trade Commission
Merck
Fish and Richardson
Baxter
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.